Navigation Links
Opportunities in Biological Technology

Business Opportunities in Spain's Fast-Growing Biotechnology Industry

MADRID, July 9 /PRNewswire/ -- - INVEST IN SPAIN would like to invite you to take part in an online seminar entitled "Business Opportunities in the Biotechnology, Pharma and Life Sciences Sector", in which business opportunities will be presented for foreign companies in the sector in S...

Health Care Innovations and Opportunities Attract Attendees from 40 Countries and Delegations from 12 to 6th Annual World Health Care Congress

China, India, Israel, many more to attend global event for health care leaders in businesses, government, April 14-16, 2009, Washington , D.C. WASHINGTON, March 31 /PRNewswire/ -- The 6th Annual World Health Care Congress, April 14-16, Washington, D.C., is pleased to announce sev...

RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference

BOSTON, March 17 /PRNewswire/ -- RainDance Technologies, Inc., a privately held provider of innovative microdroplet-based solutions for human health and disease research, today announced it will be shipping its first commercial Sequence Enrichment Solution this month and reviewed the company's opp...

PharmSource Introduces Proprietary Resource for Identifying New Business Opportunities in Bio/Pharma

PharmSource Lead Sheet upgrades database resources to help companies serving biotech/pharma industry to find new business opportunities and market intelligence. Springfield, VA (PRWEB) November 24, 2008 -- In response to challenging economic times, PharmSource Informati...

Universal Bioenergy, Inc. Seeks Algae Feedstock Companies for Acquisition, Alliance, and Joint Venture Opportunities for Biodiesel Production

NETTLETON, Miss., Nov. 7 /PRNewswire-FirstCall/ -- Universal Bioenergy, Inc. (Pink Sheets: UBRG) CEO, Dr. Richard Craven, stated, "Algae can become a prominent source of energy, and with several new algae technology companies emerging, it is a good time to form alliances. We have identified an...

New Opportunities in X-Ray Based Surgical Navigation With Ziehm NaviPort 3D

Ziehm Imaging and BrainLAB Improve Intra-Operative Imaging With Navigation for More Gentle, Less Invasive Surgery NUREMBERG and MUNICH, Germany, October 6 /PRNewswire/ -- Ziehm Imaging and BrainLAB have developed the Ziehm NaviPort 3D interface, representing an important step fo...

U.S. Hospital Sales Opportunities Maximized Through Functional Optimization

CHAPEL HILL, N.C., Aug. 15 /PRNewswire/ -- The U.S. hospital marketplace is multifaceted and can be divided into multiple market segments. In this challenging marketplace, pharmaceutical and biotechnology sales people must negotiate increasingly complex organizational and decision-making struc...

Unmet Needs Provide Challenges and Opportunities for Rheumatoid Arthritis Drug Developers According to MedPredict Report

SCOTTSDALE, Ariz., Feb. 26 /PRNewswire/ -- MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for pharma and biotech companies with a stake in the market for Rheumatoid Ar...

GPhA Annual Meeting Focuses on Industry Opportunities and Challenges for 2008

BOCA RATON, Fla., Feb. 12 /PRNewswire/ -- More than 400 generic industry leaders, financial experts and political officials gathered today for the Generic Pharmaceutical Association (GPhA) Annual Meeting to discuss the critical issues facing the generic industry in 2008. With the theme of "Gen...

Targanta to Present at 9th Annual Mass Opportunities Investment Conference

Presentation to be Webcast at 11:45 am ET on November 8, 2007 CAMBRIDGE, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Targanta Therapeutics Corporation (Nasdaq: TARG ) today announced its participation in the Massachusetts Biotechnology Council's (MBC's) annual MASS Opportunities Investment C...

2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies

Ninth Annual Biotechnology Investor Conference, November 8, Features Private and Small to Mid-cap Public Growth Companies Renowned Investment Banker and Biotechnology Company Start-up Leader Stelios Papadopoulos, PhD Provides Keynote Address BOSTON, Oct. 16 /PRNewswire/ -...

Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments

- JDRF President's goal is to progress research from academic settings to clinical trials and marketable drugs and therapeutics - BOSTON, Oct. 2 /PRNewswire-USNewswire/ -- The promise of research utilizing adult and embryonic stem cells is broader than most might think, including not onl...

Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities

London, July 20 /PRNewswire/ -- There has been a recent upsurge in Merger & Acquisition (M&A) activities in the pharmaceutical and biotechnology space. While the economic downturn and related credit crunch has had an impact, this alone cannot account for the recent M&A mania,...

New RISI Report Analyzes South American Tree Farm and Biomass Energy Investment Opportunities

BEDFORD, Mass., July 14 /PRNewswire/ -- RISI, the leading information provider for the global forest products industry, today announced the publication of the South American Tree Farm Update: Opportunities for Investment in Forest Industry and Biomass Energy Plantations . This new study upda...

Amylin Pharmaceuticals Highlights 2009 Value Creation Opportunities

Product and Operational Targets Presented At JPMorgan Healthcare Conference SAN FRANCISCO, Jan. 12 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today announced product and operational targets for 2009 that provide the opportunity to transform diabetes and obesity ...

Two Metabolex Projects Recognized in Windhover's Top 10 Lists for Partnering Opportunities

HAYWARD, Calif., Nov. 3 /PRNewswire/ -- Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced that two of its programs (MBX-2982 and MBX-8025) have been recognized in Windhover's "To...

CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities

SARASOTA, Fla., Sept. 29 /PRNewswire-FirstCall/ -- CPC of America, Inc. (OTC Bulletin Board: CPCF.OB) today announced that it had retained FTI Capital Advisors, LLC, the investment banking subsidiary of FTI Consulting, Inc., to explore strategic alternatives for the Company. As CPC of Americ...

Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities

WOBURN, Massachusetts, March 17 /PRNewswire/ -- Mercury Therapeutics, Inc. (MTI), a company that discovers and develops orally active protein kinase targeted drugs, announces that it has retained Marquant Partners LLC ( http://www.marquantpartners.com ) to advise on its strategic and partnerin...

BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities

BIRMINGHAM, Ala., Jan. 10 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced Thomas J. Simon, M.D. has joined BioCryst as a consultant and interim Chief Medical Officer. Dr. Simon brings more than 20 years of expertise in global pharmaceutical development...

SBC merger with AT&T could open opportunities in Wisconsin

After SBC Communications' Monday announcement that it plans to buy its former parent AT&T , rival communications companies are keeping their eyes open for new opportunities. Drew Petersen, director of legislative affairs for TDS Telecom , said the merger between SBC and AT&T is a sign that S...

British, Wisconsin firms explore life-science opportunities together

Madison, Wis. Representatives of the British Consulate-General, which is looking to expand its bio and health technology investments, met Wisconsin companies on Tuesday for a luncheon to explore opportunities for collaboration. "We're looking for companies with complimentary products or compl...

RFID medical devices - Opportunities and challenges

June's column on information technology opportunities noted that the FDA sees radio frequency identification (RFID) technology as critical for the long-term safety and integrity of the U.S. drug supply. RFID allows pharmaceutical packages to be tracked, traced and authenticated throughout the c...

Big opportunities with small businesses

"We are men of action. Lies do not become us." - Dread Pirate Roberts, The Princess Bride Small business owners sometime seem like a big challenge to marketers. They can be difficult to target and easily dissuaded. Given the right opportunity, however, small business owners can also be ti...

Challenging times for FDA and drug companies equals IT opportunities

Even before the intense scrutiny that started in September when Vioxxs manufacturer removed the drug from the market due to safety concerns, the U.S. Food and Drug Administration and the pharmaceutical industry faced a bumpy road. One of the biggest challenges has been the pipeline problem, th...

Growth spurts

... and other fields of science." Says Dahmen, "From a microscopist's point of view, the ability to observe nanoparticles in liquid solution opens new opportunities in an area that has traditionally been off-limits because electron microscopes require vacuum conditions. We can now see directly what before could on...

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

...e continue to work with our investment bankers on potential strategic transactions, including mergers and other business combinations that could yield opportunities to increase shareholder value and provide additional resources for us to develop our Controlled Delivery Technology (CDT(R)) platforms. However, we ar...

Novavax Reports Second Quarter 2009 Financial Results

...x may pursue additional funding through the potential sale of equity securities, other non-dilutive financing, or additional partnering agreements, as opportunities arise. About Novavax Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infe...

Synthetech Reports First Quarter Fiscal 2010 Results

...credit crises on the Company's business and customers; strength of the biopharmaceutical customer base; adequacy of project pipeline to provide market opportunities and Company performance for the balance of fiscal 2010. Words such as "believe," "anticipate," "expect," "estimate," "project," "will be," "will cont...

Knighted Adds Industry Pioneer and Entrepreneur to Senior Management Team

...ed founder & CEO Daniel Napoli's visionary approach to how users interact with supply chain software is innovative and differentiated creating new opportunities for driving efficiencies and productivity. Knighted is well positioned to enhance their customers' global supply chains for today and the future." ...

The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.

...s to support the mission of the National Institutes of Health - improving health through scientific discovery. The Foundation identifies and develops opportunities for innovative public-private partnerships and collaborations and brings together industry, academia, and the philanthropic community in support of th...

Microbia Names John McCarthy to Senior Management Team

...nd development-focused organizations to broad commercial entities will be vital as we accelerate our plans to take advantage of the large-scale market opportunities afforded by our technologies." "I'm very pleased to be joining Microbia at this important time in its development," stated Mr. McCa...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

... primary receptor responsible for human salt taste perception. These enhancers represent 12 diverse sample classes and therefore may provide numerous opportunities for the discovery of a new flavor ingredient that enables a reduction in the use of salt. The enhancers are being optimized and evaluated in taste te...

AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma

...d resources to pursue R D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult t...

Beckman Coulter Completes Acquisition of Olympus' Lab-Based Diagnostics Business

...xpands our geographic reach and scale. We are confident that the combination of Olympus diagnostics with our business will provide many cross-selling opportunities -- the most compelling being promotion of Beckman Coulter's leading Immunoassay products to the loyal base of Olympus' chemistry customers. "...

Insmed to Host Second Quarter 2009 Conference Call

...ase, including statements relating to planned clinical study design, regulatory and business strategies, plans and objectives of management and growth opportunities for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to diff...

CuraGen Reports Second Quarter 2009 Financial Results

... that targets GPNMB. "We continue to be very positive about the development opportunities for CR011 in breast cancer and melanoma," commented Dr. Timothy M. Shannon,...e proposed settlement of the shareholder class action lawsuits, development opportunities for CR011 in breast cancer and melanoma and the expected timing for present...

Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights

... results from this study later this year and intends to explore partnership opportunities as a potential path to continue the development of ANA773. Reported ...tudy within the next several weeks; and (viii) plans to explore partnership opportunities as a potential path to continue the development of ANA773. Such forward-lo...

Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors

... vertebrae. About Cardium Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, partnering and other ec...

NIST scientists study how to stack the deck for organic solar power

... the polymer. The electrical properties of the interface also change dramatically. The resultant structure gives the light-generated photocurrent more opportunities to reach the proper electrodes and reduces the accumulation of fullerenes at the film bottom, both of which could improve the photovoltaic's efficienc...

BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol

...g dedicated energy crops, agricultural waste, and wood products. In addition to the vast potential for biofuels, a multitude of large-scale industrial opportunities exist for the Company for products derived from the production of low-cost, biomass-derived sugars. For more information on Verenium, visit www.vereni...
Other Tags
(Date:4/15/2014)... Biologists at UC San Diego have succeeded in ... hormone responsible for growth and resistance to drought. ... studies to determine how the hormone helps plants ... by the continuing increase in the atmosphere,s carbon ... achievement appears in the April 15 issue of ...
(Date:4/15/2014)... Looking at the question of how social behavior has ... universities in Mainz and Basel have gained new insights ... simply compete for food. Rather the siblings share what ... absent," explained Dr. Jol Meunier of the Evolutionary Biology ... University of Mainz (JGU). The team of biologists from ...
(Date:4/15/2014)... (April 15, 2014) The American Association of Anatomists ... All awards will be presented during the Closing ... Hotel on Tuesday, April 29th at 7:30 p.m. during ... , The 2014 award winners are: , ... PhD, of the Icahn School of Medicine at Mount ...
Breaking Biology News(10 mins):Biologists develop nanosensors to visualize movements and distribution of plant hormone 2Sibling cooperation in earwig families gives clues to early evolution of social behavior 2American Association of Anatomists 2014 award winners 2
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
Other Contents